Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - CAPITAL EXPENDITURES
Capital Expenditures ALLO - Allogene Therapeutics, Inc.
-1.52 M
LAST VALUE
73.41%
2 YEAR CAGR
14.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR